Bharath Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 30-12-2024
- Paid Up Capital ₹ 0.90 M
as on 30-12-2024
- Company Age 10 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 99.35%
(FY 2022)
- Profit 109.07%
(FY 2022)
- Ebitda 54.34%
(FY 2022)
- Net Worth 12.05%
(FY 2022)
- Total Assets 50.47%
(FY 2022)
About Bharath Life Science
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.90 M, as per Ministry of Corporate Affairs (MCA) records.
Venkata Gorla, Sudhakar Nandyala, and Narmada Nandyala serve as directors at the Company.
- CIN/LLPIN
U24100TG2014PTC094705
- Company No.
094705
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jul 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Bharath Life Science Private Limited offer?
Bharath Life Science Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibacterial Drugs, Pharma Ingredients & Raw Materials, API Intermediate, Common Disease Medicines, Antihistamines, API Impurities.
Who are the key members and board of directors at Bharath Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkata Gorla  | Director | 02-Jul-2014 | Current |
| Sudhakar Nandyala | Director | 02-Jul-2014 | Current |
| Narmada Nandyala | Director | 16-Mar-2020 | Current |
Financial Performance of Bharath Life Science.
Bharath Life Science Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 99.35% increase. The company also saw a substantial improvement in profitability, with a 109.07% increase in profit. The company's net worth Soared by an impressive increase of 12.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bharath Life Science?
In 2020, Bharath Life Science had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Bharath Life Science India Private LimitedActive 10 years 10 monthsVenkata Gorla, Sudhakar Nandyala and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bharath Life Science?
Unlock and access historical data on people associated with Bharath Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bharath Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bharath Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
